Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin.

Polyglutamine expansions within different proteins are associated with nine different neurodegenerative diseases. There is growing interest in understanding the roles of flanking sequences from disease-relevant proteins in the intrinsic conformational and aggregation properties of polyglutamine. We report results from atomistic simulations and circular dichroism experiments that quantify the effect of the N-terminal 17-residue (Nt17) segment of the huntingtin protein on polyglutamine conformations and intermolecular interactions. We show that the Nt17 segment and polyglutamine domains become increasingly disordered as polyglutamine length (N) increases in Nt17-Q(N) constructs. Hydrophobic groups within Nt17 become sequestered in intramolecular interdomain interfaces. We also show that the Nt17 segment suppresses the intrinsic propensity of polyglutamine aggregation. This inhibition arises from the incipient micellar structures adopted by monomeric forms of the peptides with Nt17 segments. The degree of intermolecular association increases with increasing polyglutamine length and is governed mainly by associations between polyglutamine domains. Comparative analysis of intermolecular associations for different polyglutamine-containing constructs leads to clearer interpretations of recently published experimental data. Our results suggest a framework for fibril formation and identify roles for flanking sequences in the modulation of polyglutamine aggregation.

[1]  Feng Ding,et al.  The Length Dependence of the PolyQ-mediated Protein Aggregation* , 2007, Journal of Biological Chemistry.

[2]  S. Brahmachari,et al.  Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions , 1999, FEBS letters.

[3]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[4]  Zbyszek Otwinowski,et al.  Secondary structure of Huntingtin amino-terminal region. , 2009, Structure.

[5]  Osamu Onodera,et al.  Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. , 2008, Human molecular genetics.

[6]  Dalaver H. Anjum,et al.  Polyglutamine disruption of the huntingtin exon1 N-terminus triggers a complex aggregation mechanism , 2009, Nature Structural &Molecular Biology.

[7]  E. Altschuler,et al.  Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[8]  Ronald Wetzel,et al.  Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Ronald Wetzel,et al.  Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. , 2004, Molecular cell.

[10]  A. Pastore,et al.  The Interplay between PolyQ and Protein Context Delays Aggregation by Forming a Reservoir of Protofibrils , 2006, PloS one.

[11]  Regina M Murphy,et al.  Reconsidering the mechanism of polyglutamine peptide aggregation. , 2007, Biochemistry.

[12]  A. Pastore,et al.  Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. , 2005, Journal of molecular biology.

[13]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[14]  Annalisa Pastore,et al.  Domain architecture of the polyglutamine protein ataxin‐3: a globular domain followed by a flexible tail , 2003, FEBS letters.

[15]  Zoya Ignatova,et al.  In-cell Aggregation of a Polyglutamine-containing Chimera Is a Multistep Process Initiated by the Flanking Sequence* , 2007, Journal of Biological Chemistry.

[16]  Ronald Wetzel,et al.  Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions , 2006, Proceedings of the National Academy of Sciences.

[17]  F. Ferrone,et al.  Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.

[18]  Reinhard Pahl,et al.  Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. , 2007, Journal of molecular biology.

[19]  R. Pappu,et al.  A polymer physics perspective on driving forces and mechanisms for protein aggregation. , 2008, Archives of biochemistry and biophysics.

[20]  Carol K Hall,et al.  Side-chain interactions determine amyloid formation by model polyglutamine peptides in molecular dynamics simulations. , 2006, Biophysical journal.

[21]  Zoya Ignatova,et al.  Extended Polyglutamine Tracts Cause Aggregation and Structural Perturbation of an Adjacent β Barrel Protein* , 2006, Journal of Biological Chemistry.

[22]  Feng Ding,et al.  Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases , 2005, PLoS Comput. Biol..

[23]  Xuhui Huang,et al.  The predicted structure of the headpiece of the Huntingtin protein and its implications on Huntingtin aggregation. , 2009, Journal of molecular biology.

[24]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[25]  Andreas Matouschek,et al.  Inefficient degradation of truncated polyglutamine proteins by the proteasome , 2004, The EMBO journal.

[26]  Ronald Wetzel,et al.  Polyglutamine homopolymers having 8–45 residues form slablike β‐crystallite assemblies , 2005, Proteins.

[27]  R. Wetzel,et al.  Mutational analysis of the structural organization of polyglutamine aggregates , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Olson,et al.  Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration , 2007, PLoS genetics.

[29]  H. Paulson,et al.  Polyglutamine neurodegeneration: protein misfolding revisited , 2008, Trends in Neurosciences.

[30]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  X. Daura,et al.  Peptide Folding: When Simulation Meets Experiment , 1999 .

[32]  Andreas Vitalis,et al.  Thermodynamics of beta-sheet formation in polyglutamine. , 2009, Biophysical journal.

[33]  Andreas Vitalis,et al.  Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. , 2008, Journal of molecular biology.

[34]  F. Walker.  Huntington's disease , 2007, The Lancet.

[35]  H. Paulson,et al.  Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. , 2003, Current opinion in genetics & development.

[36]  P. Pandolfi,et al.  SUMO Modification of Huntingtin and Huntington's Disease Pathology , 2004, Science.

[37]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[38]  Regina M Murphy,et al.  Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation. , 2009, Journal of molecular biology.

[39]  Andreas Vitalis,et al.  Characterizing the conformational ensemble of monomeric polyglutamine , 2005, Proteins.

[40]  Ronald Wetzel,et al.  Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Andreas Vitalis,et al.  Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. , 2007, Biophysical journal.

[42]  He Li,et al.  N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking , 2008, The Journal of Neuroscience.

[43]  Jingyuan Li,et al.  Single homopolypeptide chains collapse into mechanically rigid conformations , 2009, Proceedings of the National Academy of Sciences.

[44]  A. Ben-Shaul,et al.  Molecular Theory of the Sphere-to-Rod Transition and the Second CMC in Aqueous Micellar Solutions , 2001 .

[45]  Christopher A Ross,et al.  N-Terminal Proteolysis of Full-Length Mutant Huntingtin in an Inducible PC12 Cell Model of Huntington’s Disease , 2007, Cell cycle.

[46]  S. Lindquist,et al.  Structural insights into a yeast prion illuminate nucleation and strain diversity , 2005, Nature.

[47]  R. Cole,et al.  Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells* , 2009, Journal of Biological Chemistry.

[48]  Andreas Vitalis,et al.  ABSINTH: A new continuum solvation model for simulations of polypeptides in aqueous solutions , 2009, J. Comput. Chem..

[49]  J T Finch,et al.  Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[51]  Folding and Fibril Formation of the Cell Cycle Protein Cks1* , 2006, Journal of Biological Chemistry.

[52]  Ronald Wetzel,et al.  Oligoproline effects on polyglutamine conformation and aggregation. , 2006, Journal of molecular biology.

[53]  R. L. Baldwin,et al.  Parameters of helix–coil transition theory for alanine‐based peptides of varying chain lengths in water , 1991, Biopolymers.

[54]  Vidya N. Nukala,et al.  The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. , 2007, Human molecular genetics.

[55]  A Mitsutake,et al.  Generalized-ensemble algorithms for molecular simulations of biopolymers. , 2000, Biopolymers.

[56]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.